ImmuneOnco Biopharmaceuticals has shown Chinese biotechs are far from immune to the pressures to prioritize pipelines. | ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing, China.

China possessing a majority of biotech manufacturing capabilities would not only transfer economic opportunity away from the U.S., it would increase American dependency on China. There is also an ...

This week, medical tech firm Medtronic opted for tapping into China's biotech advancements. On Monday, it launched a digital healthcare innovation base at BioPark in the Beijing Economic-Technological ...

This week, medical tech firm Medtronic opted for tapping into China's biotech advancements. On Monday, it launched a digital healthcare innovation base at BioPark in the Beijing Economic ...